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Abstract
Several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration
with ubiquitinated inclusions (FTLD-U) are characterized by inclusion bodies formed by TDP-43 (TDP). We established cell
and transgenic Drosophila models expressing TDP carboxyl terminal fragment (ND251 and ND207), which developed
aggregates recapitulating important features of TDP inclusions in ALS/FTLD-U, including hyperphosphorylation at
previously reported serine
403,404,409,410 residues, polyubiquitination and colocalization with optineurin. These models were
used to address the pathogenic role of hyperphosphorylation in ALS/FTLD-U. We demonstrated that hyperphosphorylation
and ubiquitination occurred temporally later than aggregation in cells. Expression of CK2a which phosphorylated TDP
decreased the aggregation propensity of ND251 or ND207; this effect could be blocked by CK2 inhibitor DMAT. Mutation of
serines
379,403,404,409,410 to alanines (S5A) to eliminate phosphorylation increased the aggregation propensity and number of
aggregates of TDP, but mutation to aspartic acids (S5D) or glutamic acids (S5E) to simulate hyperphosphorylation had the
opposite effect. Functionally, ND251 or ND207 aggregates decreased the number of neurites of Neuro2a cells induced by
retinoic acid or number of cells by MTT assay. S5A mutation aggravated, but S5E mutation alleviated these cytotoxic effects
of aggregates. Finally, ND251 or ND251S5A developed aggregates in neurons, and salivary gland of transgenic Drosophila,
but ND251S5E did not. Taken together, our data indicate that hyperphosphorylation may represent a compensatory
defense mechanism to stop or prevent pathogenic TDP from aggregation. Therefore, enhancement of phosphorylation may
serve as an effective therapeutic strategy against ALS/FTLD-U.
Citation: Li H-Y, Yeh P-A, Chiu H-C, Tang C-Y, Tu BP-h (2011) Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation. PLoS ONE 6(8):
e23075. doi:10.1371/journal.pone.0023075
Editor: Stephen D. Ginsberg, Nathan Kline Institute and New York University School of Medicine, United States of America
Received February 8, 2011; Accepted July 12, 2011; Published August 5, 2011
Copyright:  2011 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Grant from National Science Council and Academia Sinica, Taipei, Taiwan (TMiIBMTP2009091) http://web1.nsc.gov.tw/mp.aspx?mp=7 and http://www.
sinica.edu.tw/main_e.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: btu@ibms.sinica.edu.tw
Introduction
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar
degeneration with ubiquitinated inclusions (FTLD-U) have been
recognized as two entities within a spectrum of neurodegenerative
diseases in light of overlapped clinical presentations and shared
neuropathological lesions characterized by ubiquitinated inclusion
bodies first recognized in a subset of patients [1,2]. Recently, Tar
DNA-binding protein (TARDBP) gene-encoded product TDP-43
(TDP) was discovered as the major component of the signature
inclusion bodies in ALS/FTLD-U [3,4], and several other
neurodegenerative diseases, collectively called TDP proteinopathy
[5,6]. TDP pathology also co-existed in Alzheimer’s disease [7],
dementia with Lewy bodies [8], and Huntington’s disease [9].
These studies have firmly established TDP as one of the important
protein molecules in the pathogenesis of several neurodegenerative
diseases.
TDP is a nuclear RNA-binding protein. It affects HIV
infectivity [10], promotes exon-9 skipping of the CFTR transcript,
and is important for neurological function [11,12,13,14], which
may be linked to its versatile roles involved in exon-7 inclusion of
the SMN transcript [15], neurofilament light mRNA stabilization
[16], regulation of mRNAs dynamics in synapses [17], and
regulation of expression of let-7b microRNA which in turn
modulates several important transcripts involved in neurodegen-
eration and synapse formation [18].
TDP inclusions were found in neurological diseases caused by
mutations in genes valosin-containing protein [19,20], progranulin
[21,22,23,24], dynactin [25] and optineurin [26]. Mutations in
TARDBP gene were identified in familial ALS [27,28,29,30,31],
confirming its causal role in the pathogenesis of ALS. TDP in
ALS/FTLD-U undergoes pathognomonic alterations, including
cytoplasmic translocation, putative carboxyl terminal cleaved
fragment [32], and hyperphosphorylation [3,4]. Recently, eluci-
dation of the role these changes played in TDP aggregation took
the central stage. Cytoplasmic translocation and cleavage were
shown to promote TDP inclusions [32,33,34,35]; however,
hyperphosphorylation remains less characterized.
Dr. Hasegawa and colleagues elegantly showed that ser379,
ser403/ser404 and ser409/ser410 residues of tdp were phosphor-
ylated in als/ftld-u inclusions, presumably by casein kinases (cks) 1
and 2 [36,37,38], which has been validated in subsequent studies
[39] and other diseases [9,40]. He proposed hyperphosphorylation
as a precursor change toward tdp inclusions. In this study, our data
suggested alternatively that hyperphosphorylation was a compen-
satory mechanism against tdp aggregation.
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Generation of TDP constructs
peGFPTDP was generated by cloning BamHI/HindIII fragment
of full length TDP (fTDP) into peGFPC3 (Clontech) after RT-PCR
from HEK293T cells (Cat #CRL-11268 from American Type
Culture Collection, VA, USA) using SuperScript III Reverse
Transcription kit (Invitrogen) and primers: 59ATCGATGG-
ATCCTCTGAATATATTCGGGTAAC39;5 9ATCGATAAGC-
TTCTACATTCCCCAGCCAGAAG39.p eGFPND104 and pe-
GFPND251 were generated using peGFPTDP as template with
primers 59GGAAGCTTGCCACCATGTCTGAATATATTCG-
G39 and 59GAAGCTTGCCACCATGGATTTAATAGTGT-
TG39;5 9GGAAGCTTGCCACCATGGGAATCAGCGTTCA-
T39 and 59CGATGTCGACCTACATTCCCCAGCCAGAAG3
9.p eGFPND207 was generated using peGFPTDP as template and
primers 59CGGGAGTTCTTCTCTCAGTAC39 and 59AA-
GCTTGAGCTCGAGATCTG39.S RAa n dS RE mutants con-
structs were generated by sequential PCRs using the peGFPTDP,
peGFPND207 or peGFPND251 as templates with primers:
59AATGCTGGTGCAGCAATTGGTTG39 or, 59AATGAAG-
GTGCAGCAATTGGTTG39 with 59AGAGCCACTATAA-
GAGTTATTTC39;5 9AATGGAGGCTTTGGCGCAGCCAT-
GGATTCTAAG39 or 59CTTAGAATCCATGGCTGCGC-
CAAAGCCTCCATT39 with 59AATGGAGGCTTTGGCGAA-
GAGATGGATTCTAAG39. To generate emGFPND207 and its
mutants, TDPwt first cloned into pCol1a1-emGFP/Blue Cla pA vector
(a gift from Dr. Alexander C. Lichter) to generate pCol1a1-
emGFPTDPwt. pCol1a1-emGFPND207 was further generated with
primers: 59CGGGAGTTCTTCTCTCAGTAC39 and 59AAGC-
TTGAGCTCGAGATCTG39. pREV-TRE-emGFPND207 was gen-
erated by subcloning emGFPND207 fragment released from
pCol1a1-emGFPND207 with SalI/Hind III into the same sites of
pREV-TRE vector (Clontech).
Antibodies
The rabbit polyclonal GFP antiserum was purchased from
Clontech (CA, USA); the rabbit polyclonal antisera pS403/404
and pS409/410, from Cosmo Bio Co. (Tokyo, Japan); the anti-
GAPDH and anti-ubiquitin mouse monoclonal antibodies (mAbs),
from Chemicon (MA, USA); the anti-Flag (M2) mAb, from Sigma
(MO, USA); the goat anti-HA tag polyclonal antibody, from
GenScript (NJ, USA); the anti-Myc (Myc.A7) mAb, from Anogen
(ON, Canada); the anti-optineurin rabbit polyclonal antiserum,
from Cayman Chemical (MI, USA). The self-generated rabbit
TDP-43 polyclonal antiserum was raised against amino acids
352,367 of human TDP (LTK Biolaboratories, Taiwan). All the
peroxidase-conjugated secondary antibodies were purchased from
Jackson ImmunoResearch (PA, USA).
Cell preparation
HEK293T cells and Neuro2a cells (Cat #CRL-11268 and
CCL-131 from American Type Culture Collection, VA, USA)
were maintained in DMEM (Gibco) with 10% fetal bovine serum
and 1% penicillin-streptomycin (Gibco). For fluorescent and
confocal microscopy studies, 1.5610
5 HEK293T cells or 5610
4
Neuro2a cells were plated on a coverslip and transfected using
Lipofectamine 2000 (Invitrogen) for specified times or 48 hrs. Cells
were then fixed with 4% paraformaldehyde/phosphate-buffered
saline (PBS) for 15 minutes at room temperature, then penetrated
with 0.2% Triton X-100/PBS for 10 minutes, stained with
appropriate antibodies and counterstained with DraQ5 (Cat
#4084S, Millipore, MA, USA) or DAPI for 10 minutes.
Analyses of aggregates
For quantitative analyses of aggregates, all samples were
visualized under the Nikon Eclipse TE-2000U microscope, and
the images were captured and processed by a SPOT RT3 digital
camera and software (Diagnostic Instruments, MI). Five represen-
tative fields per sample were taken and analyzed by MetaMorph
software (Molecular Devices, Downingtown, PA). GFP signal was
gated to exclude non-transfected cells, and the images were then
superimposed with corresponding DAPI images. The Metamorph
was used to count the total number of transfected cells. For
aggregate analyses, the GFP images were visually adjusted to
determine a common threshold across all samples to eliminate
diffuse or non-aggregated signals. The area and number of
individual aggregate were calculated with the Integrated Mor-
phometry Analysis of Metamorph. On average, ,2000 cells per
sample were counted. The average size of inclusions was calculated
by the formula: total areas of inclusions/total number of inclusions.
Statistical significance was analyzed with the student t-test.
Isolation of ND251 aggregates
ND251 aggregates vs. eGFP control were isolated as described
by Mitsui et al. [41] with some modifications. Briefly, transfected
HEK293T cells or Neuro2a cells were lysed with RIPA buffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS)
plus protease inhibitors, phosphatase inhibitors and 1 mg/mL
DNase I (all from Sigma) on ice for 30 minutes with shaking. Cell
lysates were harvested, sonicated for 20 seconds, and then loaded
into FACSAria cell sorter (BD Biosciences). The flow rate was
adjusted to ,4000 events/second, and the intensity of GFP
fluorescence was used to gate the cell lysates. The collected
materials from P1 and P2 fractions were centrifuged at 14 K rpm
for 10 min at 4uC, and then observed by Eclipse TE-2000U
inverted fluorescence microscope. The materials were then
solubilized in 100 mL urea buffer (100 mM Tris-Cl pH 6.8, 4%
SDS, 20% glycerol, 0.05% Bromophenol blue and 8 M Urea) for
further studies.
Assay of the solubility of Hyper- and un-phosphorylated
ND251 from isolated inclusions
ND251 aggregates were isolated as described in the previous
section. About 3.2610
7 particles were spun down by 1,3000 rpm
(SW41 rotor, Beckman) for 10 min. Pellets were solubilized and
sonicated in 600 mL of buffer (8 M Urea/50 mM Tris-Cl pH 7.5/
150 mM NaCl/1.43% b-ME). 100 mL aliquots were inserted into
the Thermo Slide-ALyzer Mini Dialysis Unit (Cat No. 69550) and
dialyzed against 500 mL buffer (50 mM Tris-Cl pH 7.5/150 mM
NaCl) containing 0, 0.5, 1, 2 or 4 M Urea buffer for 16 hrs. The
dialyzed samples were centrifuged at 100,000 g (TLA100.2 rotor,
Backman) for 2 hrs. Supernatants (soluble fractions) were saved
and the pellets (insoluble fractions) were dissolved in 200 mL2 6
SDS/8 M Urea buffer. 1/80 of RIPA and urea samples were
electrophoresed by 10% SDS-PAGE. Immunoblotting were
performed with self-generated anti-TDP antiserum which recog-
nized both Hyper- and un-phosphorylated ND251. Digital images
were captured with LAS-3000 imaging system (Fujifilm, Japan)
and the intensity of individual bands was quantified by
ImageQuant (Molecular Dynamics). The solubility was obtained
by the formula: intensity of protein in supernatant/the intensity of
protein in supernatant+that in pellet.
Protein solubility and immunoblotting
Transfected HEK293T or Neuro2a cells were sequentially
extracted with ice-cold RIPA buffer supplemented with protease
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for 20 seconds and then centrifuged at 13 K rpm for 10 minutes
at 4uC. The supernatants were designated soluble (R) fraction.
The RIPA extraction was repeated once again. The insoluble
pellets were then sonicated and solubilized in urea buffer. After
centrifuge, the supernatants were insoluble (U) fraction. 1/20 of
RIPA and urea samples were resolved by 10% SDS-PAGE,
transferred to polyvinylidene difluoride membrane (Millipore), and
then probed with primary and secondary antibodies to be
visualized with Immobilon chemiluminescent reagents (Millipore).
Digital images were captured with LAS-3000 imaging system
(Fujifilm, Japan) and the intensity of individual bands was
quantified by ImageQuant (Molecular Dynamics).
Neurite outgrowth assay
Transfected Neuro2a cells were grown in culture medium
containing 10 mM retinoic acid (Sigma) and 1% fetal bovine serum
to allow for differentiation for 48 hrs. Differentiated cells were
observed under Eclipse TE-2000U microscope, and corresponding
phase contrast and fluorescent images were captured by a SPOT
RT3 digital camera. Only cells with green fluorescence signal were
included for further analysis. The neurites were defined as cellular
processes §2 times of diameter of cell body. On average, ,200
cells were counted per sample and experiment sets were done in
triplicates. The statistical significance was analyzed by the
Student’s t-test.
Cell proliferation assay (MTT assay)
In Neuro2a cells, pTet-off (Clontech) was co-transfected with either
pemGFP, pemGFPND207, pemGFPND207S5A or pemGFPND207S5E
to achieve highest expression of truncated TDP-43 aggregates.
After transfection for 6 hours, 2000 cells were seeded into 96 wells
with 100 mL culture medium. At different time point, 10 mLo f
5 mg/ml MTT solution (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphe-
nyl tetrazolium bromide, Sigma M2128) were added to each well.
After incubation at 37uC for 3 hours, the insoluble formazan
product was dissolved in 0.1 N HCl in anhydrous isopropanol and
absorbance at l=570 nm was read. The OD value of truncated
TDP-43 groups was divided by the OD value of emGFP control
group and results presented as percentage of control group (as
100%).
Generation of Transgenic Drosophila models
ywhsFLP; Actin-Gal4.y+.UAS-b-galactosidase [42], UAS-DsRed,
GMR-Gal4 and elav-Gal4/Cyo were obtained from Bloomington
Stock Center. UAS-ND251, UAS-ND251S5A and UAS-ND251S5E
(all tagged with eGFP) transgenic flies were generated by injecting
pUAST constructs to fly eggs carrying transposase (D2–3).
Random expression of ND251 variants in salivary gland
ywhsFLP; Actin-Gal4.y+.UAS-b-galactosidase flies were crossed
with transgenic flies with UAS-ND251 or its variants and cultured
at 25uC. When the progeny grew to second larval stage, vials were
heat-shocked at 37uC for 30 minutes to induce random expres-
sion. Then, larvae of the third instar stage were examined by Zeiss
fluorescence dissecting microscope, and the salivary glands were
dissected out for further analysis with LSM 510 Meta confocal
microscope (Zeiss).
Pan-neuronal expression of ND251 variants in transgenic
flies
Male flies of UAS-DsRed; elav-Gal4/+ were crossed with UAS-
ND251 variants transgenic flies. Third instar larvae were examined
by dissecting fluorescence microscope, and dissected to eliminate
guts and other organs. The remnants were fixed with parafor-
maldehyde and counterstained with DAPI for further analysis with
confocal microscope.
Results
Truncated TDP having higher aggregation propensity
than full length TDP
eGFP-fused full length (fTDP) and three truncated forms of
TDP with N-terminal 104 (ND104), 207 (ND207) and 251
(ND251) amino acids deleted were used in this study to investigate
the differential effect of individual domains of TDP on aggregation
propensity (Fig. 1A). ND207 was specifically created to model after
the 25 kDa carboxyl terminal cleaved fragments in ALS/FTLD-U
cases [32]. fTDP was mainly diffusely distributed in nucleoplasm
like the endogenous TDP, but aggregates were found in a low
percentage (1.360.3%) of transfected HEK293T cells. In contrast,
ND104, ND207 and ND251 were expressed more in cytoplasm
than in nuclei for lack of nuclear localization signal (NLS), and
formed aggregates in 25.962.8%, 4.660.7% and 37.066.0% of
transfected cells, respectively (Fig. 1B and 1C). As expected,
ND104, ND207 and ND251 aggregates localized mainly in the
cytoplasm (80.8%, 81.1% and 95.9% respectively) due to the
deletion of the nuclear localization signal (NLS) located in the N-
terminus. The aggregates formed by the individual truncated TDP
did not differ in size (18.862.1 mm
2 in average), and were
significantly bigger than those formed by fTDP (10.461.8 mm
2)
(Fig. 1D). Western blot analyses revealed changes in the solubility
of these transgenic proteins corresponding to their aggregation
propensities. As shown in Fig. 1E, fTDP was highly soluble in the
RIPA buffer with only trace amount of insoluble (aggregated)
protein found in urea fraction. In contrast, all truncated forms of
TDP exhibited substantial increases in their insoluble pools.
Notably, the pattern of insoluble ND251 revealed a shorter
fragment and high molecular weight smear, reminiscent of that of
TDP inclusions in ALS/FTLD-U [3,4]. These results showed that
both fTDP and truncated TDP species formed aggregates, but the
latter had higher aggregation propensity than the former, and the
carboxyl terminus to be essential for TDP aggregation in the cell
models.
ND251 aggregates recapitulating important features of
TDP inclusions in ALS/FTLD-U
To determine if the TDP aggregates developed in our cell
culture system served as useful models for TDP inclusions in ALS/
FTLD-U cases, hyperphosphorylation and polyubiquitination
were characterized in both non-neuronal cell line HEK293T
and a neuroblastoma cell line Neuro2a. Western blot analysis
revealed strong signals of phosphorylated Ser
403/Ser
404 and
Ser
409/Ser
410 epitopes in the insoluble fractions of truncated
TDP species (Fig. S1). Given the highest aggregation propensity,
ND251 was used most in the following studies, with validation
using ND207. As shown in Fig. 2A and 2B, ND251 aggregates in
293T and Neuro2a cells contained phosphorylated Ser
403/Ser
404
and Ser
409/Ser
410 epitopes and were ubiquitinated. Consistently,
exogenously expressed flag-tagged ubiquitin (Flag-Ub) was incor-
porated into the ND251 aggregates (Fig. 2A). Very recently,
optineurin protein was shown to colocalize with TDP-positive
inclusion bodies in ALS [26]. Interestingly, optineurin also
coexisted with ND251 aggregates (Fig. 2B).
To further characterize these inclusions biochemically, aggre-
gated and non-aggregated ND251, represented by the P1 and P2
fraction, respectively, were isolated from transfected cells using
Hyperphosphorylation Reduces TDP-43 Aggregation
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isolated P1 materials were in fact aggregates, indicative of high
purity of aggregates (right lower panel in Fig. 2C and Fig. 2D).
Again, Western blot analysis revealed strong ubiquitin signal with
smearing, and phosphorylated Ser
403/Ser
404, and Ser
409/Ser
410
epitopes in these isolated ND251 aggregates, but weak or no signal
in P2 fraction or non-aggregated ND251 or control eGFP samples
in HEK293T (Fig. 2E) and Neuro2a cells (Fig. 2F). Taken
together, these data demonstrated that ND251 aggregates closely
resembled ALS/FTLD-U inclusions not only in the intrinsic
properties of TDP elements, but also in their extrinsic properties
evidenced by interacting with optineurin, supporting their use as
feasible cell models.
Aggregation propensity of TDP decreased by
hyperphosphorylation-mimetic mutations
To investigate the effect of the hyperphosphorylation on the
formation of TDP inclusions, we generated fTDP and ND251
mutants with the five serine residues (379, 403, 404, 409 and 410)
mutated to either alanine (S5A) (phosphorylation-deficient),
aspartic acid (S5D) or glutamic acid (S5E) (phosphorylation-
mimetic). The phosphorylation-mimetic properties of these
mutants were first characterized by the phospho-specific antisera.
As expected, S5D and S5E mutants of fTDP and ND251 were
clearly recognized by anti-pS403/404 or anti-pS409/410 antisera,
but the S5A mutants were not (Fig. S2). Notably, the S5D and S5E
had an apparent molecular weight larger than the fTDP or S5A,
an additional feature consistent with hyperphosphorylation form
of TDP. These data supported the hyperphosphorylation-mimetic
property of S5D and S5E.
To determine if phosphorylation status impacted TDP on its
aggregation, we first investigated the aggregation propensity of
fTDP vs. the single, double phosphorylation sites mutants as well
as S5A, S5D or S5E mutants (Fig. S3A and S3B). fTDP, S5A, S5D
or S5E exhibited primarily a diffuse nucleoplasmic pattern with
few aggregates ; however, Western blot analysis revealed a mild
increase in the amount of S5A partitioned into the urea (U)
fraction, when compared with fTDP or S5E or S5D (Fig. S3C). In
addition, filter trap assay which is another method widely used to
study aggregation propensity showed a decrease in the signal of
Figure 1. Formation of inclusions by truncated TDP. (A) A diagram illustrating the domain structure of TDP along with various eGFP-fused N-
terminal truncated constructs used in this study. (B) Micrograph montage of 293T cells expressing fTDP and truncated forms of TDP (ND104, ND207
and ND251). Inclusion bodies formed by truncated TDP-43 were indicated by arrows. Scale bar=20 mm( C) Quantitative analysis of the number of
inclusions per 1000 transfected cells. Please note that ND251 formed the highest number of inclusions among all (P,0.00001). (D) Average size (mm
2)
of TDP inclusions measured by Metamorph software. The inclusions formed by truncated TDP were larger than those of fTDP in size. *, P,0.05. (E)
Western blot analysis of soluble and insoluble portions of various forms of TDP protein. An increase in TDP partitioned into urea (U) fraction was
consistently observed in all three truncated TDP samples. GAPDH was used as loading control. The number indicated the fold change in insoluble
fraction of TDP quantified by ImageQuant. R: RIPA buffer.
doi:10.1371/journal.pone.0023075.g001
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suggested that hyperphosphorylation status might decrease, rather
than increase, the aggregation propensity of fTDP.
We next examined the effect of the same hyperphosphorylation
site mutations on the aggregation propensity of truncated TDP
species, and found these mutations exerted a much more
significant impact on the truncated TDP than fTDP. The
numbers of aggregates formed by hyperphosphorylation-mimetics
ND251S5D and ND251S5E significantly decreased by 50% and
65%, respectively, in HEK293T (Fig. 3A and 3B) and by 50% and
25%, respectively, in Neuro2a cells (Fig. 3D and 3E). In contrast,
an increase in the number of aggregates by 15% and 34%
(statistically significant) was noted for ND251S5A in HEK293T
(Fig. 3B) and Neuro2a cells (Fig. 3E) in comparison with ND251.
Consistently, quantitative analyses of the corresponding Western
blots showed a decrease in the solubility of the ND251S5A in
comparison with ND251; however, ND251S5D and ND251S5E
proteins became highly soluble in RIPA buffer in both 293T
(Fig. 3C) and Neuro2a (Fig. 3F) cells.
Since the ,25 kDa cleaved fragment was hyperphosphorylated
to a much higher extent than full length TDP in ALS/FTLD-U
[38], the same experiments were repeated with ND207 which
modeled after this fragment. Similarly, the number of aggregates
formed by ND207S5E dramatically decreased by 91% in Neuro2a,
and by 56% in HEK293T cells when compared with ND207 (Fig.
S4A and S4E; quantified in Fig. S4B and S4F), and the number of
aggregates of ND207S5A increased by 13% in Neuro2a, although
the number remained comparable to that of ND207 in HEK293T
cells. The aggregates formed by ND207S5A decreased by 46% in
size and that of ND207S5E inclusions, by 67% in Neuro2a cells
(Fig. S4C); however, no significant difference in size was noted for
inclusions formed by the ND207, ND207S5A or ND207S5E in
293T cells (Fig. S4G). Western blot analyses showed that RIPA
solubility of ND207S5A decreased or remained unchanged in
comparison with ND207, but ND207S5E became highly soluble in
both cell lines (Fig. S4D and S4H).
To rule out the possibility that the aggregation propensity of
truncated forms of TDP might be altered by the large eGFP tag,
similar experiments were repeated with myc-tagged truncated
TDP (as described in Text S1). Similar to eGFP-ND207, Myc-
ND207 also formed ubiquitinated aggregates which colocalized
with optineurin in Neuro2a (Fig. S5B) and HEK293T (Fig. S5D)
cells. Myc-ND207S5E formed significantly fewer aggregates in
both cell lines (Fig. S5A and S5C; quantified in Fig. S5E). In
addition, in contrast with Myc-ND207 and Myc-ND207S5A,
Myc-ND207S5E was highly soluble in RIPA buffer (Fig. S5F).
These data agreed with the results obtained with eGFP-
ND207S5E.
Figure 2. ND251 aggregates recapitulating important features of TDP inclusions in ALS/FTLD-U. Confocal micrographs of HEK293T (co-
expressing flag-tagged ubiquitin) (A) andNeuro2a(B) cellsexpressing ND251, stained with anti-pS403/404 or pS409/410 antiserum(red),anti-flag mAb,
anti-ubiquitin (Ub) or anti-optineurin (OPTN). Scale bar=20 mm. (C) Flow cytometry profile of the GFP fluorescence signal of cell lysates from 293T cells
(left upper), 293T cells expressing eGFP (right upper) and 293T cells expressing ND251 (left lower). Peak 1 (P1) in ND251 lysates was formed by ND251
aggregates. Both fractions were collected by FACSAria cell sorter. Isolated P1 materials of the ND251 samples (right lower) reached .96% of purity. (D)
Phase contrast (left) and fluorescent (right) micrographs of the isolated P1 particles viewed with Nikon Eclipse TE-2000U fluorescent microscope. All of
the visible structures with the phase contrast lens emitted bright green fluorescence, validating their identity as ND251 inclusions. Western blot of
collected P1 (aggregates) and P2 (non-aggregates) materials of 293T (E) and Neuro2a (F) cells expressing eGFP (Ctrl) or ND251 probed with anti-pS403/
404, pS409/410, anti-ubiquitin (Ub) and anti-eGFP antibodies. As noted, the pattern recapitulated that of TDP inclusions in ALS/FTLD-U.
doi:10.1371/journal.pone.0023075.g002
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made and tested. Unfortunately, none of these could be expressed
in either HEK293T or Neuro2a and other cell lines. The carboxyl
terminus is predicted to be a disordered region by PONDR [43],
lack of expression of these ND251 might be caused by rapid
degradation after synthesis. Notably, the myc-tagged ND207 had
much higher aggregation propensity than eGFP-tagged counter-
part (69.961.8% vs. 4.660.7%). In addition, the presence of
eGFP stabilized the expression of ND251 in comparison with myc
tag. These results showed that the tags could influence the
property of the fused segment of TDP to some extent. In spite of
this, our data supported the notion that hyperphosphorylation
negatively impacted TDP on its ability to form inclusions.
Additive effects of individual phosphorylation site
mutations on aggregation propensity
To investigate the effect of phosphorylation status of these five
serine residues individually or in combination, a series of
phosphorylation mutant constructs were generated and examined.
As shown in Fig. S6A and S6B, the single mutant ND251S379A,
and S403/404A and S409/410A double mutants showed no
obvious effect on the number of inclusions. In contrast,
ND251S379E and double mutants (S403/404E and S409/410E)
showed an 18% and ,40% reduction in the number of inclusions,
respectively. The number of inclusions formed by S379E/S403/
404E and S379E/S409/410E triple mutants further reduced to
,50%, and S403/404/409/410E quadruple mutant, to 38% (Fig.
S6C and S6D). The corresponding Western blot analyses also
showed a positive correlation between the number of serines
mutated to alanines and the amount of the insoluble proteins in
the urea fraction, and an inverse relationship when serines were
mutated to glutamic acids (Fig. S6E). These data demonstrated
that phosphorylation status of all five serine residues participated
in modulation of aggregation propensity of ND251, and had an
additive effect on the final outcome.
Higher solubility of hyperphosphorylated ND251 than
that of unphosphorylated ND251
To address the issue of hyperphosphorylation and aggregation
propensity without complications from artificial mutations, we
Figure 3. Effects of phosphorylation site mutations on aggregation propensity in 293T (A–C) and Neuro2a (D–F) cells. Scale
bar=20 m. (A) and (D): Confocal micrographs of 293T and Neuro2a cells expressing ND251, ND251S5A, ND251S5E or ND251S5D. (B) and (E):
Quantitative analysis of the number of aggregates per 1000 cells. Note, ND251 and ND251S5A readily formed aggregates, but ND251S5E and
ND251S5D formed fewer aggregates. (C) and (F): Western blot analyses of RIPA-solubility of ND251S5A, ND251S5E and ND251S5D normalized to
ND251. Anti-GFP antibody was used for the detection of truncated TDP. The fold change was quantified by ImageQuant software.
doi:10.1371/journal.pone.0023075.g003
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various buffers the solubility of the hyperphosphorylated species
with that of unphosphorylated species from the isolated aggregates
(Fig. 4A). As shown in Fig. 4B and 4C, hyperphosphorylated form
indeed had higher solubility than unphosphorylated form in
buffers containing 0–1 M urea. The difference in the solubility
between these two disappeared in the presence of 2 M urea or
more. These results further supported that the solubility of
truncated TDP increased with hyperphosphorylation.
The effect of Casein kinase 2 on the formation of TDP
inclusions
Casein kinases (CKs) 1 and 2 were reported to phosphorylate
these five serines, and promoted the ability of TDP recombinant
protein to form filaments in vitro. We first examined if fTDP or
truncated TDP altered endogenous CK2 activity by in vitro kinase
assay (as described in Text S1). As shown in Fig. S7, neither fTDP
nor ND207 or ND251 overexpression changed endogenous CK2
activity in neuro2a cells. Next, we expressed CK2a and examined
its effect on aggregation propensity of truncated TDP. As shown,
expression of CK2a increased phosphorylation status of 403/404
and 409/410 serine residues (Fig. S8), but decreased the amount of
insoluble ND251 in the urea fraction in both 293T and Neuro2a
cells (Fig. 5A and 5D). This effect could be blocked with DMAT, a
CK2-specific inhibitor. A similar result was also obtained with the
ND207 (Fig. 5C and 5F). To further assess if CK2a-regulated
solubility changes involved phosphorylation of these serine
residues, experiments were repeated with ND251S5A and
ND251S5E. Although the solubility of ND251S5A slightly
increased with expression of CK2a in 293T cells, but the change
was less than that of ND251. No change was observed in Neuro2a
cells (Fig. 5B). More importantly, ND251S5E remained highly
soluble with or without CK2a in either 293T or Neuro2a cells
(Fig. 5E). These data demonstrated that exogenous expression of
CK2a enhanced the solubility of truncated TDP by regulating the
phosphorylation status of these serine residues.
Cytotoxic effects of ND251 or ND207 aggregates
enhanced by S5A mutation, but alleviated by S5E
mutation
To explore the functional significance of hyperphosphorylation
on TDP aggregates, 2 different cell assays were tested. The first
was retinoic acid (RA)-induced neurite outgrowth of Neuro2a
cells. Since the undifferentiated cells contained short processes, the
neurites were defined as processes at least twice longer than that of
cell bodies. Our data showed that ND251 aggregates exerted
inhibitory effect on neurite outgrowth. Overall, percentage of
Neuro2a cells bearing extended neurites decreased from 66% in
eGFP control cells to 52% in cells expressing ND251 after 48 hrs
RA treatment (Fig. 6A). This negative impact appeared mild
because only a small percentage (13.1%61.7%) of transfected
Neuro2a cells actually developed aggregates. To address this issue
more precisely, the ND251-expressing cells were separated into 2
groups: without aggregates and with aggregates. The percentage of
Figure 4. Hyperphosphorylated ND251 had higher solubility than unphosphorylated form in vitro. (A) Experimental procedures for
analyzing the solubilities of hyper- (Hyper-p) and unphosphorlylated (Un-p) ND251 from ND251 aggregates isolated from HEK293T cells. (B)
Representative Western blot probed with homemade TDP, pS403/404 and pS409/410 antiserum to determine solubility of hyperphosphorylated and
unphosphorylated ND251 in buffers with urea concentrations as indicated. The solubility was determined by level of protein partitioned into
supernatant or pellet after dialysis against 0, 0.5, 1, 2 or 4 M Urea buffer. (C) Quantitative results on solubility of Hyper-p and Un-p ND251. Results
were quantified by ImageQuant software from quadruplicate experiments. The solubility was represented by the following formula: (intensity of
protein in supernatant)/(sum of the intensity of protein in supernatant and pellet).
doi:10.1371/journal.pone.0023075.g004
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Notably, the latter group with ND251 aggregates had a significant
drop in neurite outgrowth by 44% when compared with the
former group without aggregates (Fig. 6B). These results revealed a
cytotoxic effect of ND251 aggregates.
To examine the influence of the hyperphosphorylation on the
cytotoxicity of ND251 aggregates, neurite outgrowth was studied
in cells expressing ND251 and its mutants. As shown in Fig. 6C,
the overall percentage of Neuro2a cells with neurites further
decreased from 52% in cells expressing ND251 to 47% in cells
expressing ND251S5A, but increased to 62% in ND251S5E-
expressing cells, comparable to that in eGFP control cells (Fig. 6A).
Similar results were obtained in cells expressing emGFPND207
and its mutants. The tet-off system was used to express
emGFPND207 and its mutants because more aggregates could
be induced. As shown in Fig. 6D, cells expressing emGFPND207
and emGFPND207S5A had lower percentage of neurite-bearing
cells in comparison with emGFP control; in contrast, cells
expressing emGFPND207S5E reverted the percentage back to
the level comparable to that of the emGFP control group.
The second test was cell growth by MTT assay (Fig. 6E). Again,
the emGFPND207 and emGFPND207S5A had ,40% less
neuro2a cells on days 3 and 4. On the contrary, growth of
emGFPND207S5E expressing cells remained at a similar pace to
that of emGFP expressing cells. Taken together, these results
demonstrated that truncated TDP aggregates exerted cytotoxic
effect, which was alleviated by hyperphosphorylation-mimetic
mutations.
Phosphorylation and ubiquitination occurring after
aggregation
Previous studies [38,44] suggested hyperphosphorylation as a
precursor change in favor of formation of TDP inclusions. To
clarify this important issue, we investigated the temporal sequence
between aggregation and phosphorylation as well as ubiquitination
using our cell culture model. As shown in Video S1, Fig. 7A and
7B, ND251 aggregates started as multiple small punctate
structures distributed throughout the cytoplasm. With time, small
aggregates gained in size by self-growth and merging with other
aggregates, and eventually formed large inclusions in fewer
numbers. The majority of ND251 aggregates were phosphorylated
48 hours after transfection, but a certain percentage of aggregates,
particularly smaller ones, were not labeled with either anti-pS403/
404 or anti-pS409/410 antiserum. To examine in more details,
quantitative analysis was done in three different time points, which
revealed that the percentage of ND251 aggregates with phos-
phorylated Ser
409/410 signal increased from 33.563.7% at 8 hrs to
Figure 5. The effect of CK2a on the aggregation propensity of truncated TDP. Exogenous expression of CK2a was shown with anti-HA (HA)
mAb. Expression of CK2a decreased the insoluble fraction of ND251 in both 293T (A) and Neuro2a (D) cells, and CK2a-specific inhibitor DMAT (20 mM
for 24 hr) treatment blocked this effect. Similar results were also obtained with ND207 in 293T (C) and Neuro2a (F) cells. In contrast, CK2a either
slightly decreased or failed to change ND251S5A solubility in 293T(B) and Neuro2a (E) cells, and showed no effect on ND251S5E (B,D). GAPDH was
used as loading control. The fold change was quantified by ImageQuant software by comparing the insolubility to ND207 or ND251 relatively.
doi:10.1371/journal.pone.0023075.g005
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percentage of ND251 aggregates with phosphorylated Ser
403/404
signal also increased from 24.761.38% at 8 hrs to 32.861.63% at
48 hrs (Fig. 7B). Notably, the ubiquitination of ND251 aggregates
followed a similar trend, and increased from 1.9060.55% at 8 hrs
to 1060.51% at 24 hrs, and 16.561.73% at 48 hrs (Fig. 7C). It
was apparent that the aggregates which were not phosphorylated
were primarily small punctate structures, regardless of the time
point. These data indicated that phosphorylation and ubiquitina-
tion occurred after the formation of aggregates.
Validation of the effect of hyperphosphorylation site
mutations on aggregation propensity in transgenic
models of Drosophila melanogaster
To investigate if the hyperphosphorylation exerted a similar
inhibitory effect on the aggregation propensity of N-terminal
truncated TDP in vivo, we generated UAS-ND251, UAS-ND251S5A
and UAS-ND251S5E transgenic Drosophila melanogaster, and crossed
them with ywhsFLP; Actin-Gal4.y+.UAS-b-galactosidase flies.
Salivary gland was examined first because of its giant epithelial
cells with easily distinguishable cytoplasm and nucleus. As shown
in Fig. 8A, after heat shock at 37uC, the ND251 and ND251S5A
formed a number of aggregates distributed within nuclear and
cytoplasmic compartments. In contrast, ND251S5E was diffusely
distributed in both compartments with few aggregates observed.
To examine the aggregation propensity of these proteins in the
fly nervous system, we then crossed the transgenic flies with pan-
neuronal GAL4 flies (UAS-DsRed; elav-Gal4/+). For reasons not yet
clear, expressions of ND251 and ND251S5A were lower and more
restricted than that of ND251S5E across all different lines (data
not shown). Despite that, both ND251 and ND251S5A were
found to form aggregates in perikarya (Fig. 8B, arrow) and
dendrites (Fig. 8B, arrowhead) of multi-dendritic dendrite-
arborization (md-da) neurons [45]. Most of the aggregates were
located in the cytoplasmic/dendritic compartments, and few were
observed in nuclei. Interestingly, our fly models might be the first
to develop TDP aggregates in dendrites. In contrast, hyperpho-
sphorylation-mimetic ND251S5E showed a pattern of diffuse
distribution in nuclei, soma, and neurites (Fig. 8B).
Consistent with morphologic observations, the corresponding
Western blot analysis of the solubility revealed that ND251 and
ND251S5A extracted from heads of the adult crossed transgenic
flies were much less soluble than ND251S5E (Fig. 8C). Taken
together, our in vivo data also supported the notion that
Figure 6. Adverse effect of ND251 aggregates on neurite outgrowth. (A) Left: Merged phase contrast and GFP fluorescent micrographs of
Neuro2a cells which expressed eGFP (Ctrl) or ND251 and were induced with 10 mM retinoic acid for 48 hrs. The neurites were defined as cellular
processes 2 §times of diameter of cell body. Cell with neurites were quantified by Metamorph software. Neurites were readily noted in Ctrl cells, but
absent in two cells with ND251 aggregates. Scale bar=10 mm. Right: Quantitative bar graph on percentage of Neuro2a cells with extended neuritis.
Note: ND251 caused a decrease in neurite-bearing cells compared with Ctrl eGFP cells. (B) Quantitative results of neurite-bearing cells in ND251-
expressing Neuro2a cells with or without aggregates. As shown, Neuro2a cells with aggregates had 50% less of cells with neurites than those without
aggregates. (C) Percentage of Neuro2a cells with neurites for cells expressing ND251, ND251S5A and ND251S5E. Cells expressing ND251S5A had a
further decrease in the percentage of neurite-bearing cells in comparison with ND251. In contrast, the percentage for ND251S5E was higher than that
of ND251 and the percentage reverted to the level comparable to that of the Ctrl in Fig. 6B. (D) Percentage of Neuro2a cells with extended neurites
for cells expressing inducible emGFP, emGFPND207, emGFPND207S5A and emGFPND207S5E. Cells expressing emGFPND207 and emGFPND207S5A
had fewer neurite-bearing cells in comparison with emGFP (Ctrl) group. In contrast, the percentage for ND207S5E was higher than that of ND207 and
the percentage reverted to the level comparable to that of the Ctrl group. (E) MTT assay for neuro2a cells expressing inducible emGFP, emGFPND207,
emGFPND207S5A and emGFPND207S5E. Percentages of cell growth rated to emGFP were compared for 4 days. emGFPND207 and emGFPND207S5A
inhibited ,40% growth of neuro2a cells at day3 and day4. On the contrary, cell growth of emGFPND207S5E expressing cells is similar to that of
emGFP expressing cells. *, P,0.05.
doi:10.1371/journal.pone.0023075.g006
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ND251.
Discussion
In this study, we have established and used cell and drosophila
models to specifically address the effect of hyperphosphorylation
on the formation of TDP inclusions. Both models revealed similar
conclusions that hyperphosphorylation reduced aggregation pro-
pensity of TDP. Our studies were conducted with ND251 and
ND207 truncated TDP. The ND207 simulated the 25 kDa
cleaved TDP fragment of FTLD-U/ALS. A recent study found
a TDP fragment truncated at glutamic acid 246 in FTLD-U
brains, which differed from ND251 by only 5 amino acids [46].
This finding lends support to the pathophysiological relevance of
ND251. Furthermore, ND251 and ND207 aggregates shared
similar properties in our study and recapitulated pivotal features of
diseased TDP inclusions, such as hyperphosphorylation, poly-
ubiquitination and colocalization with optineurin. Therefore, our
models might well serve as feasible tools to probe into some
essential issues relevant to TDP pathology.
TDP undergoes several pathognomonic changes in ALS/
FTLD-U, such as aberrant cytoplasmic translocation, 25 kDa
carboxyl terminal fragment by putative protease cleavage and
hyperphosphorylation. Several recent studies were designed to
elucidate the role of the pathognomonic changes of TDP in regard
to formation of TDP inclusions and diseases. For instance,
cytoplasmic translocation and putative protease cleavage were
shown in these studies as important precursor changes for TDP
inclusions [32,33,34,35,47,48]. Consistent with this, we also found
that TDP deleted of 104 amino acids and more from amino
terminus exhibited higher propensity for aggregation than full
Figure 7. Phosphorylation and ubiquitination of ND251 aggregates increased with time. Confocal micrographs of Neuro2a cells
expressing ND251 were stained with (A) anti-pS409/410, (B) anti-pS403/404 and (C) anti-Ubiquitin antiserums. Scale bar=10 mm. ND251 aggregates
with phosphorylated 409/410, phosphorylated 403/404 or ubiquitinated epitopes at different time point were calculated by MetaMorph software.
*, P,0.05.
doi:10.1371/journal.pone.0023075.g007
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terminus, and had the highest aggregation propensity among the
three truncated forms studied here. Our recent study showed that
the D1 peptide derived from the glycine-rich domain of TDP
indeed readily formed fibrils [43]. Therefore, the carboxyl
terminus is likely the region responsible for self-aggregation in
ALS/FTLD-U. TDP is known to interact with multiple proteins
involved in mRNA processing, translation and microRNA
biogenesis [49,50]; however, these interactions appear to be lost
when TDP forms aggregates [51]. The carboxyl terminus is
predicted to be a disordered region by PONDR [43], consistent
with its reported role in protein interactions [52,53,54]. In fact,
TDP in cells and animals is highly soluble, but recombinant TDP
protein is very prone to aggregate (data not shown). These data
strongly indicate that protein interactions help prevent TDP from
aggregation in cells. Notably, the great majority of .30 mutations
in gene TARDBP in familial ALS occur within the carboxyl
terminal region. It is probable that mutations may lead to
aggregation by disrupting physiological protein interactions. The
role of amino terminus needs further study, but it may help TDP
maintain normal structure and interaction with other proteins.
This notion provides a rational model to explain why protease
cleavage/truncation increases formation of TDP inclusions.
Concerning hyperphosphorylation, the seminal discovery by
Hasegawa et al. [38], and several subsequent studies [37,39,55]
have firmly established a tight link between the inclusions of ALS/
FTLD-U and hyperphosphorylation at serine379, serine403,
serine404, serine409 and serine410. However, the cause-effect
relationship between these two remains to be described. In the
same study, Dr. Hasegawa showed that recombinant CKs was
capable of phosphorylating these serine residues and promoting
fibrillation of full length TDP in vitro [36,38]. Their findings
suggested that, as cytoplasmic translocation and protease cleavage,
hyperphosphorylation also contributed to formation of TDP
inclusions. Therefore, we were surprised by the results that
hyperphosphorylation-mimetic mutations in fact decreased the
aggregation propensity of the truncated TDP (ND251 and
ND207) and probably fTDP as well. Given our data that
differently tagged truncated TDP and their mutants behaved
similarly, the possibility that these results were an artifact induced
Figure 8. Aggregation propensity of ND251, ND251S5A and ND251S5E in transgenic Drosophila model. (A) Confocal micrograph of
aggregates formed by ND251 and ND251S5A in the salivary gland of third instar larvae. Hyperphosphorylation-mimetic ND251S5E appeared diffusely
distributed in the nuclei and cytoplasm. Green: ND251 variants, red: phalloidin, blue: DAPI. (B) ND251 or ND251S5A aggregates in the soma (arrow)
and dendrite (arrowhead) of dda neurons. In contrast, ND251S5E was diffusely distributed in dendrite and axon. Green: ND251 variants tagged with
GFP, red: DsRed revealing neurite structures, blue: DAPI. (C) Western blot analysis of solubility of ND251, ND251S5A and ND251S5E in vivo As shown,
solubility of ND251S5E was much higher than the other two. Adult heads expressing ND251 variants were collected and extracted in RIPA buffer.
Relative solubility was performed by comparing the normalized densitometry of each to ND251S5E. Scale bar, 25 mm (A), 10 mm (B).
doi:10.1371/journal.pone.0023075.g008
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between our results and previous studies may well lie in different
systems that were used. Dr. Hasegawa’s study was done with
recombinant protein in vitro, but our study was conducted in cell
and drosophila models. The property of TDP is different in vivo
and in vitro for lack of interacting proteins. Interestingly, during the
course of our study, Dr. Hu and colleagues showed that the
aggregation propensity of the C-terminal 25 kDa and 15 kDa
fragments of TDP was significantly reduced by phospho-mimetic
mutations at serine 409 and 410 residues [56], which supported
the concept that phosphorylation decreased aggregation propen-
sity of TDP fragments.
Dr. Braak [44] identified novel small dash-like aggregates in
ALS neurons using the pS409/410 antiserum. Given their
phosphorylated, but ubiquitin- and p62-negative features, these
aggregates were interpreted as early lesions which resulted in TDP
inclusions, in line with Dr. Hasegawa’s proposal. However, this
study was conducted with phospho-specific antiserum, the
possibility that an existence of earlier unphosphorylated lesions
has not been formally ruled out. Earlier, Mori et al [57] discerned
three morphologically distinct forms of TDP ‘‘pre-inclusions’’ in
ALS, namely linear wisps, dot-like inclusions, and granular
structures, and suggested these pre-inclusions matured into
skein-like inclusions, speculated round inclusions and large
granular aggregates, respectively. But the phosphorylation status
of these inclusions remains to be determined. Our live cell imaging
study showed that ND251 aggregates started as numerous tiny
structures and gained in size by continuous growth and/or fusion
with others to form a few or single large aggregates. It is interesting
to note that Dr. Braak’s dash-like structures and Mori’s pre-
inclusions are numerous, and the mature large inclusions are few
or single in number. Therefore, ND251 aggregates are believed to
follow a maturation process similar to that proposed by Mori et al,
and serve as a good model for us to sort this out.
One of the keys to deciphering the role of hyperphosphorylation
in regard to aggregation is to determine the temporal sequences
between these two changes. To directly address this issue, we
calculated the percentage of phosphorylated ND251 aggregates as
a function of time in our cell models. As we expected, the
percentage of phosphorylated ND251 increased with time;
however, there were always a certain percentage of inclusions
which were not phosphorylated. The phosphorylated ND251
aggregates were larger than unphosphorylated counterparts
regardless of time points. These data indicated that aggregation
occurred before phosphorylation, and the small unphosphorylated
aggregates were likely newly formed aggregate throughout the
study course. This interpretation is consistent with the fact that
ND251S5A formed aggregates despite its lack of these phosphor-
ylation sites, and ND251S5E had much lower capability to form
aggregates. Taken together, we propose that hyperphosphoryla-
tion functions as an early, if not the first line, compensatory
defense mechanism induced by the formation of TDP aggregates
to counteract the process of further aggregation or, alternatively,
to dissolve the pre-existing aggregates.
One of the subsequent key questions then is to address the fate
of the hyperphosphorylated TDP species. Although it remains to
be tested, a recent interesting study by Dr. Petrucelli and
colleagues [58] which showed that TDP aggregates were degraded
through proteasome-ubiquitin system (UPS) may have provided
an answer. In that paper, they showed that 1) knocking down the
heat shock proteins (HSPs) 70 and 90 preferentially increased the
phosphorylated species of TDP over the total TDP; 2) degradation
of phosphorylated species of TDP was slower than total pool.
Although these data were interpreted as evidences supporting the
role of hyperphosphorylation in favor of formation of TDP
aggregation, they may in fact be more consistent with an
alternative view (in concert with our data) that predicts a constant
dynamic conversion of unphosphorylated into hyperphosphory-
Figure 9. The schematic model of TDP-43 aggregation. Hyperphosphorylation of TDP-43 C-terminal fragments facilitates its disassociation
from aggregation which may result in promoting its degradation by ubiquitin proteasome system (UPS).
doi:10.1371/journal.pone.0023075.g009
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degradation (Fig. 9). From this perspective, the slower degradation
curve of phosphorylated TDP may be accounted for by the
continuous flow of the unphosphorylated pool into the hyperpho-
sphorylated pool; this view may well explain the preferential
increase in the phosphorylated species after HSP knockdown. It
will be interesting to determine if hyperphosphorylation functions
as a signal for ubiquitination and/or subsequent activation of heat
shock/polyubiquitination/protein degradation systems.
Previous studies demonstrated phosphorylation of the five serine
residues in ALS/FTLD-U inclusions. However, it is difficult to
determine the effect of individual phosphorylated residues on the
formation of inclusions. By mutating these residues singly or in
combinations, we showed that each individual serine residues
contributed to the total capability to modulate the aggregation
propensity in a cooperative, not antagonistic, fashion, and these
five serines were the key residues to modulate TDP aggregation
propensity, given the fact that S5E or S5D mutations exerted a
strong inhibition on aggregation. However, TDP aggregates exist
in ALS-FTLD-U in spite of hyperphosphorylation. One possibility
is that hyperphosphorylated species accounts for a small
percentage of aggregated TDP. This was actually shown in
previous studies [3,4]. Alternatively, all of these five serine residues
are not phosphorylated on one individual TDP protein. Our data
showed that partial phosphorylation achieved only partial
protection against aggregation. Therefore, it will be very insightful
to precisely determine the extent of phosphorylation of each TDP
molecule, and the relative abundance of TDP with one, two, three,
four or five phosphorylated serine residues in FTLD-U/ALS
inclusions.
Supporting Information
Figure S1 Western blot analysis of the phosphorylation
status of full length (fTDP) and various truncated forms
of TDP protein. The Western blots were probed with rabbit anti-
TDP(top),anti-pSer403/404(middle)oranti-pSer409/410(bottom)
anti-serum, respectively. As shown, the fTDP was RIPA-soluble (R),
and only a small amount was observed in insoluble urea (U) fraction.
In contrast, an increase in the amount of TDP partitioned into
urea (U) fraction was observed in all three truncated TDP samples
(top). The arrow indicated endogenous fTDP protein. The insoluble
fractions of all the truncated TDP samples were strongly stained
by anti-pSer403/404 or anti-pSer409/410 anti-sera, suggestive of
hyperphosphorylation of these aggregated TDP species.
(TIF)
Figure S2 The phosphorylation-mimetic properties of
S5D and S5E mutants characterized by the phospho-
specific antisera. (A) RIPA-extracts of Neuro2a expressing S5D
or S5E mutants of fTDP (left panel) and ND251 (right panel) were
examined by anti-GFP or phospho-specific antisera. As expected,
both S5D and S5E mutants of fTDP and ND251 were recognized
by anti-pS403/404 or anti-pS409/410 antisera, but the S5A
mutants were not. (B) Confocal micrographs of ND251S5A,
ND251S5D and ND251S5E in Neuro2a cells. Only aggregates
formed by ND251S5D and ND251S5E were recognized by anti-
pS403/404 or anti-pS409/410 antisera, those by ND251S5A were
not. These data indicated that the S5D and S5E shared
conformations similar to the hyperphosphorylation epitopes. Scale
bar=20 mm.
(TIF)
Figure S3 Mild change in aggregation propensity of
hyperphosphorylation-deficient or phosphorylation-mi-
metic mutant of fTDP. (A) Fluorescent micrographs of
HEK293T cells expressing fTDP or its mutants with serine379,
serines403/404 or serines409/410 mutated either to alanine (A) or
glutamic acid (E). These mutants shared a diffuse nucleoplasmic
pattern with that of fTDP. (B) Mutants of full length TDP with all
five serine residues mutated either to alanine (S5A), aspartic acid
(S5D) or glutamic acid (S5E) also exhibited a diffuse nucleoplasmic
pattern. No significant changes in the number of inclusions were
observed. Scale bar in (A) and (B)=20mm. (C) Western blot
analyses of TDP solubility by sequential extracting Neuro2a cells
expressing fTDP, S5A, S5D and S5E with RIPA (R) and urea (U)
buffers. As shown, all three proteins were highly soluble evidenced
by abundant amounts of proteins in R (soluble) fraction. However,
an appreciable increase in the U fraction occurred in S5A sample,
suggesting a mild increase in the aggregation propensity. GAPDH
was used as loading control. Notably, the S5D and S5E migrated
more slowly compared with fTDP and S5A, recapitulating the
feature of hyperphosphorylated form of TDP in human ALS/
FTLD-U. (D) Filter trap analyses of 20 mg of Neuro2a lysate
expressing eGFP, fTDP, S5A or S5E mutant scanned by Typhoon
9410 (GE) to reveal GFP signal. The signal represented aggregated
proteins trapped on the cellulose acetate membrane (Toyo Roshi
Kaisha, Japan). Notably, the S5E was less trapped than fTDP and
S5A. Since fTDP formed aggregates in a small percentage of cells,
this finding indicated that hyperphosphorylation-mimetic muta-
tion rendered fTDP less prone for aggregation.
(TIF)
Figure S4 The effect of phosphorylation site mutations
on aggregation propensity of ND207. Confocal micrographs
of ND207, ND207S5A and ND207S5E in Neuro2a cells (A)o r
HEK293T cells (E). Scale bar in (A) and (E)=20mm. ND207S5E
not only formed significantly fewer aggregates in both Neuro2a (B)
and HEK293T (F) cells compared with ND207 or ND207S5A,
but also significantly impacted the average size of aggregates in
Neuro2a cells (C). No significant change in the average size of
inclusions was noted in HEK293T cells (G). The solubility of
ND207, ND207S5A and ND207S5E in Neuro2a (D) and
HEK293T (H) cells were examined by sequential extraction with
Western blot. Compared with ND207, ND207S5A was either
equally or more insoluble, whereas ND207S5E was highly soluble
in RIPA buffer. The fold change of insolubility was calculated with
intensity measured by ImageQuant software.
(TIF)
Figure S5 The aggregation propensities of myc tagged
ND207, ND207S5A and ND207S5E were similar to those
of eGFP-tagged ND207 counterparts. Confocal micrographs
of myc tagged ND207, ND207S5A and ND207S5E immuno-
stained by anti-myc antibody in Neuro2a cells (A) or HEK293T
cells (C). Scale bar=20 mm. Similar to eGFP tagged ND207, myc-
ND207 also readily formed aggregates which colocalized with
both ubiquitin and optineurin signals in Neuro2a cells (B) and
HEK293T cells (D). Compared with myc-ND207 or myc-
ND207S5A, myc-ND207S5E formed significantly fewer aggre-
gates in HEK293T (E) cells agreed with the quantification done by
eGFP-ND207S5E. Moreover, the solubility of ND207,
ND207S5A and ND207S5E in HEK293T (H) cells were
examined by sequential extraction with Western blot. Compared
with ND207, ND207S5A showed a decrease in the solubility (R)
fraction, but an increase in the insoluble (U) fraction; whereas,
ND207S5E was highly soluble in RIPA buffer.
(TIF)
Figure S6 An inverse relationship between the aggrega-
tion propensity of ND251 with the number of serine
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montages of ND251 with single/double mutations (A), and triple/
quadruple mutations (C) in HEK293T cells. Scale bar in (A) and
(C)=20mm. Quantitative analysis (B and D) revealed a trend of
gradual decrease in the numbers of inclusions formed by ND251
with the increase in the number of SRE mutations. However,
SRA mutants did not exhibit a significant change in the ability to
form inclusions. *, P,0.05; **, P,0.005; #,P ,0.0005. (E)
Consistently, Western blot analysis of the RIPA solubility of the
ND251 mutants revealed a consistent increase in solubility with an
increase in the number of SRE mutations. The SRA mutations
did not significantly alter the solubility of ND251.
(TIF)
Figure S7 CK2 activities in neuro2a cells were not
altered by truncated TDP-43 series overexpression.
Endogenous CK2 activity was examined by an in vitro kinase
assay employing the measurement of [c-
32P]ATP incorporation
into the CK2-specific substrate peptide RRREEETEEE. Neither
full length TDP-43 (fTDP) nor truncated TDP-43 series (ND207
or ND251) overexpression changed CK2 activity in neuro2a cells.
c.p.m.: counts per minute.
(TIF)
Figure S8 An increase in the phosphorylation status of
truncated TDP by CK2a. Expression of CK2a decreased the
insoluble ND251 in urea (U) fraction (left panel). However, CK2a
increased the phosphorylation status at both serine 403/404 and
serine 409/410 residues of the insoluble ND251 in HEK293T cells
by ,2.64 and 1.9 folds, respectively, after normalization. These
data supported the notion that hyperphosphorylation decreased
the aggregation propensity of ND251. GAPDH was used as
loading control and exogenous expression of CK2a was shown
with anti-HA (HA) mAb.
(TIF)
Text S1 Supplemental methods.
(DOC)
Video S1 Live cell image of ND251 aggregates in
Neuro2a cells for 24 hrs. eGFP tagged ND251 were
transfected into Neuro2a cells grown in chamber for live cell
imaging. After transfection for 4 hrs, images were captured by
Axiovert 200 M inverted microscopes (Zeiss) with 406 oil-
immersion objectives. Both phase and fluorescence images were
captured every 30 minutes for 24 hrs. MetaMorph software
(Molecular Devices) was used for data recording and processing.
(AVI)
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